Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis Pigmentosa

Retinitis pigmentosa refers to a diverse group of hereditary diseases that lead to incurable blindness, affecting two million people worldwide. As a common pathology, rod photoreceptors die early, whereas light-insensitive, morphologically altered cone photoreceptors persist longer. It is unknown if...

Full description

Saved in:
Bibliographic Details
Published inScience (American Association for the Advancement of Science) Vol. 329; no. 5990; pp. 413 - 417
Main Authors Busskamp, Volker, Duebel, Jens, Balya, David, Fradot, Mathias, Viney, Tim James, Siegert, Sandra, Groner, Anna C, Cabuy, Erik, Forster, Valérie, Seeliger, Mathias, Biel, Martin, Humphries, Peter, Paques, Michel, Mohand-Said, Saddek, Trono, Didier, Deisseroth, Karl, Sahel, José A, Picaud, Serge, Roska, Botond
Format Journal Article
LanguageEnglish
Published Washington, DC American Association for the Advancement of Science 23.07.2010
The American Association for the Advancement of Science
American Association for the Advancement of Science (AAAS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Retinitis pigmentosa refers to a diverse group of hereditary diseases that lead to incurable blindness, affecting two million people worldwide. As a common pathology, rod photoreceptors die early, whereas light-insensitive, morphologically altered cone photoreceptors persist longer. It is unknown if these cones are accessible for therapeutic intervention. Here, we show that expression of archaebacterial halorhodopsin in light-insensitive cones can substitute for the native phototransduction cascade and restore light sensitivity in mouse models of retinitis pigmentosa. Resensitized photoreceptors activate all retinal cone pathways, drive sophisticated retinal circuit functions (including directional selectivity), activate cortical circuits, and mediate visually guided behaviors. Using human ex vivo retinas, we show that halorhodopsin can reactivate light-insensitive human photoreceptors. Finally, we identified blind patients with persisting, light-insensitive cones for potential halorhodopsin-based therapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0036-8075
1095-9203
DOI:10.1126/science.1190897